AU2001234508A1 - Methods for treatment of restenosis using adenoviral vectors and transgene products - Google Patents

Methods for treatment of restenosis using adenoviral vectors and transgene products

Info

Publication number
AU2001234508A1
AU2001234508A1 AU2001234508A AU3450801A AU2001234508A1 AU 2001234508 A1 AU2001234508 A1 AU 2001234508A1 AU 2001234508 A AU2001234508 A AU 2001234508A AU 3450801 A AU3450801 A AU 3450801A AU 2001234508 A1 AU2001234508 A1 AU 2001234508A1
Authority
AU
Australia
Prior art keywords
restenosis
treatment
methods
adenoviral vectors
transgene products
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001234508A
Inventor
Abraham Scaria
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genzyme Corp
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp filed Critical Genzyme Corp
Publication of AU2001234508A1 publication Critical patent/AU2001234508A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70575—NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14033—Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
    • C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2001234508A 2000-02-02 2001-01-22 Methods for treatment of restenosis using adenoviral vectors and transgene products Abandoned AU2001234508A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US49624800A 2000-02-02 2000-02-02
US09496248 2000-02-02
PCT/US2001/002046 WO2001057228A1 (en) 2000-02-02 2001-01-22 Methods for treatment of restenosis using adenoviral vectors and transgene products

Publications (1)

Publication Number Publication Date
AU2001234508A1 true AU2001234508A1 (en) 2001-08-14

Family

ID=23971868

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001234508A Abandoned AU2001234508A1 (en) 2000-02-02 2001-01-22 Methods for treatment of restenosis using adenoviral vectors and transgene products

Country Status (2)

Country Link
AU (1) AU2001234508A1 (en)
WO (1) WO2001057228A1 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1175859A (en) * 1997-09-08 1999-03-23 R P R Jienseru Kk Apoptosis-related gene expressible virus vector system
WO1999041398A1 (en) * 1998-02-11 1999-08-19 Genvec, Inc. Vectors, cells and methods for the production of deleterious viral eukaryotic gene transfer vectors
WO1999062940A2 (en) * 1998-05-30 1999-12-09 Collateral Therapeutics, Inc. Methods of altering cardiac cell phenotype
JP2002541855A (en) * 1999-04-21 2002-12-10 ジェンザイム・コーポレーション Adenovirus vectors containing nucleic acids encoding immunomodulatory molecules
WO2000073477A1 (en) * 1999-05-27 2000-12-07 Genzyme Corporation Methods for induction of tolerance to adenoviral vectors and transgene products
WO2001027254A2 (en) * 1999-10-12 2001-04-19 Fritz Schwarzmann Gene transfer vectors for treating autoimmune diseases and diseases with immunopathogenesis by therapy

Also Published As

Publication number Publication date
WO2001057228A1 (en) 2001-08-09

Similar Documents

Publication Publication Date Title
AU4205100A (en) Methods and compositions for the treatment of pancreatitis
AU2000260550A1 (en) Treatment of skin damage using polyenylphosphatidylcholine
AU6529900A (en) Novel cloning methods and vectors
AU2072201A (en) Agents and methods for the treatment of proliferative diseases
AU4806100A (en) P element derived vector and methods for its use
AU2003200722A1 (en) Compositions and methods for the treatment of tumor
AU2003200731A1 (en) Compositions and methods for the treatment of tumor
AU2003200740A1 (en) Compositions and methods for the treatment of tumor
AU2495200A (en) Compositions and methods for the treatment of tumor
EP1429617A4 (en) Methods for sterilizing preparations of digestive enzymes
AU6528800A (en) Methods and apparatuses for radiation treatment
AU2001257532A1 (en) Adenoviral vectors for tumor specific gene expression and uses thereof
AU3169495A (en) Gene therapy for restenosis using an adenoviral vector
AU2001280576A1 (en) Tissue-specific self-inactivating gene therapy vector
AU2002365077A1 (en) Methods and products related to non-viral transfection
AU5679899A (en) Reduction of surfactant inactivation in pulmonary surfactant therapy
GB9924370D0 (en) Sprayable hair treatment products
AU2002338616A1 (en) Vector processor architecture and methods performed therein
AU3356000A (en) L-arginine based formulations for treating diseases and methods of using same
AU2001234508A1 (en) Methods for treatment of restenosis using adenoviral vectors and transgene products
AU3735900A (en) Methods of treatment and prevention of restenosis
IL150485A0 (en) Method of achieving persistent transgene expression
AU5549800A (en) Metallurgical treatment apparatus
AU5617200A (en) Nodavirus-based dna expression vector and uses thereof
AU3331400A (en) Hair setting implement and hair setting apparatus having such implement